Business Description
Inovio Pharmaceuticals Inc
NAICS : 325414
SIC : 2836
ISIN : US45773H2013
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 4.81 | |||||
Equity-to-Asset | 0.69 | |||||
Debt-to-Equity | 0.26 | |||||
Debt-to-EBITDA | -0.23 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -11.86 | |||||
Beneish M-Score | -3.06 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -59.5 | |||||
3-Year EBITDA Growth Rate | 20.2 | |||||
3-Year EPS without NRI Growth Rate | 7.7 | |||||
3-Year FCF Growth Rate | 26 | |||||
3-Year Book Growth Rate | -44.2 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 31.76 | |||||
9-Day RSI | 41.62 | |||||
14-Day RSI | 45.69 | |||||
6-1 Month Momentum % | 174.99 | |||||
12-1 Month Momentum % | 18.47 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.6 | |||||
Quick Ratio | 3.6 | |||||
Cash Ratio | 3.41 | |||||
Days Sales Outstanding | 463.27 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -13.5 | |||||
Shareholder Yield % | -1.07 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -16036.9 | |||||
Net Margin % | -16240.14 | |||||
FCF Margin % | -14986.42 | |||||
ROE % | -79.81 | |||||
ROA % | -55.73 | |||||
ROIC % | -242.41 | |||||
ROC (Joel Greenblatt) % | -839.13 | |||||
ROCE % | -72.61 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 287.88 | |||||
PB Ratio | 2.07 | |||||
Price-to-Tangible-Book | 2.07 | |||||
EV-to-EBIT | -1.3 | |||||
EV-to-EBITDA | -1.33 | |||||
EV-to-Revenue | 209.17 | |||||
EV-to-Forward-Revenue | 217.54 | |||||
EV-to-FCF | -1.4 | |||||
Price-to-Median-PS-Value | 9.34 | |||||
Price-to-Net-Current-Asset-Value | 2.44 | |||||
Price-to-Net-Cash | 2.65 | |||||
Earnings Yield (Greenblatt) % | -76.92 | |||||
FCF Yield % | -45.19 |